Steve Bland

speaker

983 appearances 8 recordings 1 series first heard May 2026 last heard 6 Aug

Steve Bland’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 8 in all, peaking in Jul 2026 with 3.

Appearances

newest first · ▶ plays the moment

Taking Control of Cancer · Episode 64: Breaking cancer news - July 2026 · 31 Jul 2026 podcast

But the results are in and around 64,000 people responded to the 2025 edition of the survey, giving an average score of 8.92 out of 10.

Um, and look, I mean, record seven, 700,000 treatments were carried out in this year we're talking about.

So, you know, the caveat is it is quite a small sample size, uh, but nearly nine out of 10 in terms of a rating for, you know, for cancer care, you know, sounds like a pretty good number to me.

Particularly when we're talking about an area like North East London, where there's so much difference in so many ways, cultural differences, socioeconomic differences, geographical differences, so much going on that

you know, less than 10% probably doesn't probably give the full picture.

There's going to be, you know, there's going to be people who are in certain communities who probably, you know, 0% of them have filled it in and you're not getting that data.

So that's,

you know, so much great work is going on with the Alliance.

I know to get out into those communities and, you know, really find out what, you know, what makes a difference to them, what matters to them, how we can work on the way that cancer care is delivered to make sure they get the best service possible.

Let's have a little chat.

Now the next two, Femi, I'm going to, we're going to get a bit technical here.

So this is a story about a service that was pioneered at Addenbrooke's hospital in Cambridge that could help up to three times more cancer patients benefit from whole genome sequencing and it's won a national award and been accredited for use across the UK.

We did a podcast last year.

I went up to Leeds for an event and we chatted to a few people around the use of Signatera.

And it's all about DNA testing that can inform treatment decisions for cancer patients, inform whether people might need treatment in the future as well.

And this is the way it's going, isn't it, Femi?

It's fantastic to see a lot of this innovation

Absolutely.

It's so interesting, isn't it?

As I said about my little girl, I've got twins who are three.

Showing 141–160 of 983 · page 8 of 50